🔗 Share this article

As the United States undertakes historic changes to its vaccine guidelines, one figure has surfaced unexpectedly: Tracy Beth Høeg, a Danish American physician and epidemiologist who initially gained attention by expressing skepticism about coronavirus vaccinations in the pandemic and has focused upon alleged deaths following Covid immunization in her brief position at the Food and Drug Administration.

Proposed Shifts to Childhood Vaccine Program

Public health authorities were set to reveal sweeping revisions to the pediatric vaccination calendar earlier this month, bringing the US with the Danish vaccine program, according to reports – a significant shift that would put the US at odds with much of the international standard with no evidence for public health gain. This reveal has been delayed until the coming year.

Instead of Vinay Prasad, Tracy Beth Høeg is scheduled to speak at the gathering. She was just designated temporary leader of the FDA’s drug evaluation center, the fifth appointee to run the office this calendar year.

A Shift at the Regulatory Body

Høeg's temporary position might represent a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Dr. Prasad solidify control at the FDA – and it suggests a increased emphasis upon reevaluating long-standing vaccines at the FDA.

The new acting director has frequently advocated for halting specific childhood vaccine recommendations in the US so as to align more in line with Denmark, a nation with nationalized medicine and a citizenry about the size of Wisconsin’s.

So far statements, she has kept her attention on immunizations – usually the responsibility of Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to pharmaceutical oversight.

Questions Over Background

The appointee has little discernible track record in pharmaceutical research, oversight or management, which has been standard for past heads of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a key advisor to the agency head and the vaccine center since earlier this year.

“It seems she lacks to have any of the qualifications” for running the drug-regulation department, remarked Jonathan Howard. “She lacks experience running a scientific study. She is not versed in managing a large organization. She has no expertise in drug approvals.”

Past commissioners of the center would “be deeply familiar with laws and regulations and the research of medication creation”, noted Dr. Janet Woodcock. “Objectively, she lacks the sort of resume that former directors who led the center have had.”

CDER has an vast workload at the FDA, she pointed out.

“Everybody just pays attention on the innovative therapies, but the generic drug division approves a multitude of generic drugs. There is also a biologic copycat branch, over-the-counter program and other areas, and every single one have to be looked after,” Dr. Woodcock said. “The area you overlook, that is precisely what that I always told people is going to come back to haunt you.”

There is also, a significant leadership element to the role, which manages over 5,000 staff members. “It is a massive management job, if you do it right,” Woodcock concluded.

Response and Contentious Policies

In response to concerns about Høeg’s qualifications and whether this selection indicates more teamwork among agency officials on vaccines, a spokesperson responded that the “questions stem from inaccurate premises”.

“Her experience aligns with the duties of her job,” the official explained, citing the time Dr. Høeg spent advising the FDA commissioner on “drug safety and approval science, including computerized risk analysis and vaccine surveillance”.

In her interim role, Dr. Høeg inherits the commissioner’s controversial expedited review system, a disputed expedited therapy clearance system that reportedly worried her preceding directors. “By what process are these drugs being chosen for this expedited pathway? Who is making the decisions?” Howard said. “There’s a lot of secrecy happening at the agency right now.”

Overall, he stated, “the Food and Drug Administration seems to be moving towards more relaxed rules of most medications, with the exception of shots.”

Established History on Immunizations

Regarding vaccines, Høeg has a more established, if problematic, history, some experts observe. She released a study using unverified volunteer-provided data to estimate the frequency of heart inflammation after COVID-19 immunization. She consulted for the state of Florida surgeon general Joseph Ladapo, who was said to have altered data to suggest Covid vaccines are more dangerous than they are.

Included in her “wish list” for the incoming administration included changing regulations for recently developed shots and halting “non-essential” vaccines, she remarked following the vote on a podcast. At the FDA, Høeg has according to sources proposed barring adolescent males from getting Covid vaccinations.

“She is an all-around ideologue who starts off with her preconceived notions and works backwards to fit the evidence in a highly deceptive, fraudulent way,” Dr. Howard argued.

Consolidating Power and a “Campaign of Retribution”

Høeg joined fellow skeptics, {like|